Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers focus on reversing the scarring that’s common to liver diseases.